Answers are grounded in this paper and cite their sources.
The Early Manifest Glaucoma Trial is the first adequately powered randomized trial with an untreated control arm to evaluate the effects of IOP reduction in patients with open-angle glaucoma who have elevated and normal IOP. Its intent-to-treat analysis showed considerable beneficial effects of treatment that significantly delayed progression. Whereas progression varied across patient categories, treatment effects were present in both older and younger patients, high- and normal-tension glaucoma, and eyes with less and greater visual field loss.
No takes yet. Share an insight, caveat, or question.
Anders Heijl (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: